New incident report
Incident Report Number: 2010-0492
Registrant Reference Number: Prosar 1-20977849
Registrant Name (Full Legal Name no abbreviations): FMC Corporation
Address: 1735 Market Street
City: Philadelphia
Prov / State: Pennsylvania
Country: USA
Postal Code: 19103
Human
Country: CANADA
Prov / State: BRITISH COLUMBIA
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: Dragnet (non-specific)
Yes
Unknown
Site: Res. - In Home / Rés. - à l'int. maison
Unknown
Data Subject
Sex: Female
Age: >19 <=64 yrs / >19 <=64 ans
System
Unknown / Inconnu
Yes
Unknown
Non-occupational
Contact with treated area
Amount of time between application and contact 14
Hour(s) / Heure(s)
What was the activity? re-entry
Unknown
Unknown
Unknown / Inconnu
>24 hrs <=3 days / >24 h <=3 jours
1-20977849: A reporter called on 12/09/2009 to report her exposure to an insecticide containing the active ingredient Permethrin. According to the reporter, the product was applied inside her apartment by a Pest Control Operator on 08/07/2009. The reporter waited 14 hours following application before returning to the apartment. On 08/09/2009, the reporter developed abnormal speech and red eyes. She went to the emergency room (diagnosis and treatment details were not provided) and had the apartment cleaned. The reporter's signs worsened at an unspecified time to include dry mouth, nausea, trembling, a burning sensation throughout her body, and dermatitis on her knees and elbows. The reporter stated that she moved out of her apartment one month prior to the report and has been staying with friends. The reporter was advised of the active ingredient. The reporter was also advised that dermal absorption of the active ingredient is slow, but dermal exposure to wet product may result in a temporary numbness, tingling, itching, or burning sensation that typically resolves on its own within 24 hours. Dermal exposure to wet product may result in dermatitis in susceptible individuals. The duration of signs described are not expected. With exposure to dry product, the signs described are not expected. Inhalation of product would also not be expected to result in the signs described. The reporter was advised to continue working with her physician to determine the cause of the signs. No further information was obtained.
Moderate